GZBL(SZ:002424) Zheng Quan Zhi Xing·2025-06-18 09:28Summary of Key Points Core Viewpoint - Guizhou BaiLing Pharmaceutical Group Co., Ltd. plans to provide a guarantee for its subsidiary, Anshun Dajiankang Pharmaceutical Industry Operation Co., Ltd., to secure a loan of 148 million yuan from Guizhou Bank for a period of 2 years, reflecting the company's support for its subsidiary's operational needs and long-term business development [1][4]. Group 1: Guarantee Details - The subsidiary, Anshun Dajiankang, is applying for a loan of 148 million yuan, with the company providing a guarantee of 81.4 million yuan based on its 55% ownership stake [1][4]. - The other shareholder, Anshun Medical Investment Technology Service Co., Ltd., will provide a guarantee of 66.6 million yuan based on its 45% ownership stake [4]. - The board of directors has approved the guarantee, which will be submitted for shareholder meeting review [1][2]. Group 2: Financial Position - After this guarantee, the total amount of external guarantees provided by the company and its subsidiaries will be 213.4 million yuan, which is 6.71% of the company's most recent audited net assets [4]. - The guarantees provided to external entities outside the consolidated statements amount to 24.5 million yuan, representing 0.77% of the company's most recent audited net assets [4]. - The guarantees to the subsidiary total 188.9 million yuan, accounting for 5.94% of the company's most recent audited net assets [4]. Group 3: Company and Subsidiary Information - Anshun Dajiankang was established on May 30, 2003, with a registered capital of 10 million yuan and operates in various pharmaceutical and health-related sectors [2]. - The company has a good operational and credit status, indicating its capability to repay the loan [4].